Skip to main content
. 2018 Jul 26;4(7):e00707. doi: 10.1016/j.heliyon.2018.e00707

Table 1.

Subject selection.

Database Private (CCAE)
Medicaid (MDCD)
Medicare (MDCR)
Retained Excluded Retained Excluded Retained Excluded
Met age requirement1 25,791,353 1,905,877 3,042,893
 Not in database for ≥1 year 9,529,651 577,802 815,715
 Exclusion diagnosis in past year 198,072 146,951 161,739
 Dispensed an AD in past year 1,942,436 175,260 321,987
Study cohort2 14,121,194 1,005,864 1,742,452
 No AD dispensed in 2011 13,572,434 957,464 1,664,954
 AD dispensed in 2011 but no accompanying depression diagnosis3 378,271 27,586 64,097
Incident PTD cases 170,489 20,814 13401
1

Age in 2011 was 14–60 years (inclusive) for CCAE and MDCD, or at least 65 years for MDCR.

2

The population from which the pharmaceutically treated depression patients were identified, i.e., the base population from which incidence rates were calculated.

3

To be considered an accompanying depression diagnosis, the diagnosis needed to be between 30 day before and 180 days after the AD dispensing.